Crowberry inhibits cell proliferation and migration through a molecular mechanism that includes inhibition of DEK and Akt signaling in cholangiocarcinoma

BACKGROUND: Cholangiocarcinoma (CCA) is a rare biliary adenocarcinoma related to poor clinical prognosis. Crowberry is an herbal medicine used to control inflammatory diseases and reestablish antioxidant enzyme activity. Although crowberry shows significant therapeutic efficacy in various tumors and...

Full description

Bibliographic Details
Published in:Chinese Medicine
Main Authors: Wang, Xue, Zhou, Xuebing, Zhang, Ludan, Zhang, Xin, Yang, Chunyu, Piao, Yingshi, Zhao, Jinhua, Jin, Lili, Jin, Guihua, An, Renbo, Ren, Xiangshan
Format: Text
Language:English
Published: BioMed Central 2022
Subjects:
Online Access:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9190153/
http://www.ncbi.nlm.nih.gov/pubmed/35698073
https://doi.org/10.1186/s13020-022-00623-6
id ftpubmed:oai:pubmedcentral.nih.gov:9190153
record_format openpolar
spelling ftpubmed:oai:pubmedcentral.nih.gov:9190153 2023-05-15T15:59:24+02:00 Crowberry inhibits cell proliferation and migration through a molecular mechanism that includes inhibition of DEK and Akt signaling in cholangiocarcinoma Wang, Xue Zhou, Xuebing Zhang, Ludan Zhang, Xin Yang, Chunyu Piao, Yingshi Zhao, Jinhua Jin, Lili Jin, Guihua An, Renbo Ren, Xiangshan 2022-06-13 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9190153/ http://www.ncbi.nlm.nih.gov/pubmed/35698073 https://doi.org/10.1186/s13020-022-00623-6 en eng BioMed Central http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9190153/ http://www.ncbi.nlm.nih.gov/pubmed/35698073 http://dx.doi.org/10.1186/s13020-022-00623-6 © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. CC0 PDM CC-BY Chin Med Research Text 2022 ftpubmed https://doi.org/10.1186/s13020-022-00623-6 2022-06-19T00:45:38Z BACKGROUND: Cholangiocarcinoma (CCA) is a rare biliary adenocarcinoma related to poor clinical prognosis. Crowberry is an herbal medicine used to control inflammatory diseases and reestablish antioxidant enzyme activity. Although crowberry shows significant therapeutic efficacy in various tumors and diseases, its anticancer effects and specific molecular mechanisms in CCA are poorly understood. AIM OF THE STUDY: This study was conducted to characterize crowberry effects on CCA cells behavior. MATERIALS AND METHODS: The chemical profiles of crowberry extract was qualitatively analyzed by high-performance liquid chromatography (HPLC) and HPLC–tandem mass spectrometry. MTT, colony formation and EdU assays were performed to measure cell proliferation. The effect of crowberry treatment on CCA cell migration was assessed by wound healing and migration assays. Moreover, Hoechst staining assay and flow cytometry were performed to assess the cell apoptosis rate. Western blotting was used to assess the protein expression levels of key factors associated with apoptosis, the Akt signaling pathway, and the epithelial-mesenchymal transition. A xenograft model was established and immunohistochemical and H&E staining was performed to assess crowberry antitumor effects in vivo. RESULTS: Crowberry clearly inhibited CCA cells proliferation and migration in a dose-dependent manner and induced apoptosis in vitro. Crowberry inactivated the PI3K/Akt signaling pathway by regulating DEK in vitro and significantly inhibited tumor growth by downregulating the DEK expression in xenograft models. CONCLUSION: Crowberry inhibits CCA cells proliferation and migration through a molecular mechanism that includes inhibition of DEK and Akt signaling pathway inhibition in vitro and in vivo. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13020-022-00623-6. Text Crowberry PubMed Central (PMC) Chinese Medicine 17 1
institution Open Polar
collection PubMed Central (PMC)
op_collection_id ftpubmed
language English
topic Research
spellingShingle Research
Wang, Xue
Zhou, Xuebing
Zhang, Ludan
Zhang, Xin
Yang, Chunyu
Piao, Yingshi
Zhao, Jinhua
Jin, Lili
Jin, Guihua
An, Renbo
Ren, Xiangshan
Crowberry inhibits cell proliferation and migration through a molecular mechanism that includes inhibition of DEK and Akt signaling in cholangiocarcinoma
topic_facet Research
description BACKGROUND: Cholangiocarcinoma (CCA) is a rare biliary adenocarcinoma related to poor clinical prognosis. Crowberry is an herbal medicine used to control inflammatory diseases and reestablish antioxidant enzyme activity. Although crowberry shows significant therapeutic efficacy in various tumors and diseases, its anticancer effects and specific molecular mechanisms in CCA are poorly understood. AIM OF THE STUDY: This study was conducted to characterize crowberry effects on CCA cells behavior. MATERIALS AND METHODS: The chemical profiles of crowberry extract was qualitatively analyzed by high-performance liquid chromatography (HPLC) and HPLC–tandem mass spectrometry. MTT, colony formation and EdU assays were performed to measure cell proliferation. The effect of crowberry treatment on CCA cell migration was assessed by wound healing and migration assays. Moreover, Hoechst staining assay and flow cytometry were performed to assess the cell apoptosis rate. Western blotting was used to assess the protein expression levels of key factors associated with apoptosis, the Akt signaling pathway, and the epithelial-mesenchymal transition. A xenograft model was established and immunohistochemical and H&E staining was performed to assess crowberry antitumor effects in vivo. RESULTS: Crowberry clearly inhibited CCA cells proliferation and migration in a dose-dependent manner and induced apoptosis in vitro. Crowberry inactivated the PI3K/Akt signaling pathway by regulating DEK in vitro and significantly inhibited tumor growth by downregulating the DEK expression in xenograft models. CONCLUSION: Crowberry inhibits CCA cells proliferation and migration through a molecular mechanism that includes inhibition of DEK and Akt signaling pathway inhibition in vitro and in vivo. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13020-022-00623-6.
format Text
author Wang, Xue
Zhou, Xuebing
Zhang, Ludan
Zhang, Xin
Yang, Chunyu
Piao, Yingshi
Zhao, Jinhua
Jin, Lili
Jin, Guihua
An, Renbo
Ren, Xiangshan
author_facet Wang, Xue
Zhou, Xuebing
Zhang, Ludan
Zhang, Xin
Yang, Chunyu
Piao, Yingshi
Zhao, Jinhua
Jin, Lili
Jin, Guihua
An, Renbo
Ren, Xiangshan
author_sort Wang, Xue
title Crowberry inhibits cell proliferation and migration through a molecular mechanism that includes inhibition of DEK and Akt signaling in cholangiocarcinoma
title_short Crowberry inhibits cell proliferation and migration through a molecular mechanism that includes inhibition of DEK and Akt signaling in cholangiocarcinoma
title_full Crowberry inhibits cell proliferation and migration through a molecular mechanism that includes inhibition of DEK and Akt signaling in cholangiocarcinoma
title_fullStr Crowberry inhibits cell proliferation and migration through a molecular mechanism that includes inhibition of DEK and Akt signaling in cholangiocarcinoma
title_full_unstemmed Crowberry inhibits cell proliferation and migration through a molecular mechanism that includes inhibition of DEK and Akt signaling in cholangiocarcinoma
title_sort crowberry inhibits cell proliferation and migration through a molecular mechanism that includes inhibition of dek and akt signaling in cholangiocarcinoma
publisher BioMed Central
publishDate 2022
url http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9190153/
http://www.ncbi.nlm.nih.gov/pubmed/35698073
https://doi.org/10.1186/s13020-022-00623-6
genre Crowberry
genre_facet Crowberry
op_source Chin Med
op_relation http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9190153/
http://www.ncbi.nlm.nih.gov/pubmed/35698073
http://dx.doi.org/10.1186/s13020-022-00623-6
op_rights © The Author(s) 2022
https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
op_rightsnorm CC0
PDM
CC-BY
op_doi https://doi.org/10.1186/s13020-022-00623-6
container_title Chinese Medicine
container_volume 17
container_issue 1
_version_ 1766395373117505536